Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong.
June W Y ChoonDavid B C WuH Y ChongWilliam T L LoCatherine S Y ChongW S ChungEileena M C ChuiChristopher Wai Kei LamVivian W Y LeeS C LeeKenneth Kwing-Chin LeePublished in: Journal of medical economics (2019)
From the 413 patients studied, potential annual savings is higher by early administration of PPIM in patients with NP. Analysis using multivariate linear regression based on generalized estimating equations and sensitivity analysis using a linear mixed model supported the findings.